Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: A phase i dose-escalation study (ISIDE-BT-1)

International Journal of Clinical Oncology

Volumn 18, Issue 5, 2013, Pages 784-791

  Massaccesi, Mariangela ^a   Ferro, Marica ^a   Cilla, Savino ^a   Balducci, Mario ^b   Deodato, Francesco ^a   Macchia, Gabriella ^a   Valentini, Vincenzo ^b   Morganti, Alessio G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Glioblastoma; IMRT; Phase I; Radiotherapy; Temozolomide

Indexed keywords

HEMOGLOBIN; STEROID; TEMOZOLOMIDE;

ADJUVANT THERAPY; ADULT; AGED; APHASIA; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHEMORADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; EXTERNAL OTITIS; EYE DISEASE; FEMALE; GLIOBLASTOMA; HAIR LOSS; HEADACHE; HEARING IMPAIRMENT; HEMATOLOGIC DISEASE; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LEUKOCYTE; MALE; NAUSEA; NEUROLOGIC DISEASE; NEUTROPHIL COUNT; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL; PNEUMONIA; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIATION DOSE ESCALATION; RADIATION INJURY; RADIATION RESPONSE; RESPIRATORY FAILURE; SEIZURE; SKIN EXFOLIATION; THROMBOCYTE COUNT; TREATMENT DURATION; TUMOR GROWTH;

ADULT; AGED; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; DACARBAZINE; DOSE FRACTIONATION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MAXIMUM TOLERATED DOSE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 84886095649     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-012-0462-0     Document Type: Article

References (42)

1. Chang CH, Horton J, Schoenfeld D et al (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study. Cancer 52:997-1007
2. Nakagawa K, Aoki Y, Fujimaki T et al (1998) High-dose conformal radiotherapy influenced the pattern of failure but did not improve survival in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 40:1141-1149
3. Kristiansen K, Hagen S, Kollevold T et al (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47:649-652
4. Stupp R, Mason WP, van den Bent MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996
5. Stupp R, Hegi ME, Mason WP et al (2009) Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTCNCIC trial. Lancet Oncol 10:459-466
6. Curran WJ, Scott CB, Horton J et al (1993) Recursive partitioning analysis in three Radiation Therapy Oncology Group malignant glioma trials. J Natl Cancer Inst 85:704-710
7. Amelio D, Lorentini S, Schwarz M, Amichetti M (2010) Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. Radiother Oncol 97:361-369
8. Hermanto U, Frija EK, Lii MJ et al (2007) Intensity-modulated radiotherapy (IMRT) and conventional three-dimensional conformal radiotherapy for high-grade gliomas: does IMRT increase the integral dose to normal brain? Int J Radiat Oncol Biol Phys 67:1135-1144
9. Hasegawa M, Niibe H, Mitsuhashi N et al (1995) Hyperfractionated and hypofractionated radiation therapy for human malignant glioma xenograft in nude mice. Jpn J Cancer Res 86:879-884
10. Budach W, Gioioso D, Taghian A, Stuschke M, Suit HD (1997) Repopulation capacity during fractionated irradiation of squamous cell carcinomas and glioblastomas in vitro. Int J Radiat Oncol Biol Phys 39:743-750
11. Kleinberg LR, Slick T, Enger C et al (1997) Short course radiotherapy is an appropriate option for most malignant glioma patients. Int J Radiat Oncol Biol Phys 38:31-36
12. Hulshof MCCM, Schimmel EC, Bosch DA et al (2000) Hypofractionation in glioblastoma multiforme. Radiother Oncol 54:143-148
13. Fuller CD, Choi M, Forthuber B et al (2007) Standard fractionation intensity modulated radiation therapy (IMRT) of primary and recurrent glioblastoma multiforme. Radiat Oncol 2:26
14. Chan MF, Schupak K, Burman C et al (2003) Comparison of intensity-modulated radiotherapy with three-dimensional conformal radiation therapy planning for glioblastoma multiforme. Med Dosim 28:261-265
15. Floyd NS, Woo SY, Teh BS et al (2004) Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme. Int J Radiat Oncol Biol Phys 58:721-726
16. Iuchi T, Hatano K, Narita Y et al (2006) Hypofractionated high-dose irradiation for the treatment of malignant astrocytomas using simultaneous integrated boost technique by IMRT. Int J Radiat Oncol Biol Phys 64:1317-1324
17. Narayana A, Yamada J, Berry S et al (2006) Intensity-modulated radiotherapy in high-grade gliomas: clinical and dosimetric results. Int J Radiat Oncol Biol Phys 64:892-897
18. Sultanem K, Patrocinio H, Lambert C et al (2004) The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial. Int J Radiat Oncol Biol Phys 58:247-252
19. Suzuki M, Nakamatsu K, Kanamori S et al (2003) Feasibility study of the simultaneous integrated boost (SIB) method for malignant gliomas using intensity-modulated radiotherapy (IMRT). Jpn J Clin Oncol 33:271-277
20. Thilmann C, Zabel A, Grosser KH et al (2001) Intensity-modulated radiotherapy with an integrated boost to the macroscopic tumor volume in the treatment of high-grade gliomas. Int J Cancer 96:341-349
21. Cho KH, Kim JY, Lee SH et al (2010) Simultaneous integrated boost intensity-modulated radiotherapy in patients with high-grade gliomas. Int J Radiat Oncol Biol Phys 78:390-397
22. Chen C, Damek D, Gaspar LE et al (2011) Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 81:1066-1074
23. Nakamatsu K, Suzuki M, Nishimura Y et al (2008) Treatment outcomes and dose-volume histogram analysis of simultaneous integrated boost method for malignant gliomas using intensity-modulated radiotherapy. Int J Clin Oncol 13:48-53
24. Piroth MD, Pinkawa M, Holy R et al (2009) Integrated-boost IMRT or 3-D-CRT using FET-PET based auto-contoured target volume delineation for glioblastoma multiforme-a dosimetric comparison. Radiat Oncol 4:57
25. Monjazeb AM, Ayala D, Jensen C et al (2012) A phase I dose escalation study of hypofractionated IMRT field-in-field boost for newly diagnosed glioblastoma multiforme. Int J Radiat Oncol Biol Phys 82(2):743-748
26. Panet-Raymond V, Souhami L, Roberge D et al (2009) Accelerated hypofractionated intensity-modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: a safety and efficacy analysis. Int J Radiat Oncol Biol Phys 73:473-478
27. Morganti AG, Balducci M, Salvati M et al (2010) A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. Int J Radiat Oncol Biol Phys 77:92-97
28. Fowler JF (1989) The linear-quadratic formula and progress in fractionated radiotherapy. Br J Radiol 62:679-694
29. Qi XS, Schultz CJ, Li XA (2006) An estimation of radiobiologic parameters from clinical outcomes for radiation treatment planning of brain tumor. Int J Radiat Oncol Biol Phys 64(5):1570-1580
30. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346
31. Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:20-27
32. Brandes AA, Franceschi E, Tosoni A et al (2008) MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients. J Clin Oncol 26:2192-2197
33. Kaplan FL, Meier P (1958) Nonparametric estimation from incomplete observations. Am J Stat Assoc 53:457-481
34. Chan JL, Lee SW, Fraass BA et al (2002) Survival and failure patterns of high-grade gliomas after three-dimensional conformal radiotherapy. J Clin Oncol 20:1635-1642
35. Loeffler JS, Alexander E 3rd, Hochberg FH et al (1990) Clinical patterns of failure following stereotactic interstitial irradiation for malignant gliomas. Int J Radiat Oncol Biol Phys 19:1455-1462
36. Mehta MP, Masciopinto J, Rozental J et al (1994) Stereotactic radiosurgery for glioblastoma multiforme: report of a prospective study evaluating prognostic factors and analyzing long-term survival advantage. Int J Radiat Oncol Biol Phys 30:541-549
37. National Comprehensive Cancer Network Guidelines version 2.2011 available at http://www.nccn.org/professionals/physician-gls/pdf/cns.pdf
38. Liang BC, Thornton AF Jr, Sandler HM, Greenberg HS (1991) Malignant astrocytomas: focal tumor recurrence after focal external beam radiation therapy. J Neurosurg 75:559-563
39. Chang EL, Akyurek S, Avalos T et al (2007) Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma. Int J Radiat Oncol Biol Phys 68:144-150
40. Oppitz U, Maessen D, Zunterer H, Richter S, Flentje M (1999) 3-D-recurrence-patterns of glioblastomas after ct-planned postoperative irradiation. Radiother Oncol 53:53-57
41. Kelly PJ (1993) Computed tomography and histologic limits in glial neoplasms: tumor types and selection for volumetric resection. Surg Neurol 39:458-465
42. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB (1987) Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62:450-459